Integra Lifesciences Holdings (IART) Inventory Average (2010 - 2026)

Integra Lifesciences Holdings (IART) has 17 years of Inventory Average data on file, last reported at $493.9 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 12.95% year-over-year to $493.9 million; the trailing twelve-month figure through Mar 2026 stood at $493.9 million (up 12.95% YoY), and the FY2025 full-year result was $460.9 million, up 12.6% from the prior year.
• Inventory Average advanced to $493.9 million in Q1 2026, from $490.9 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $493.9 million in Q1 2026 to a low of $315.6 million in Q3 2022.
• A 5-year average of $396.2 million and a median of $396.5 million in 2024 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average declined 3.0% in 2022 and gained 19.17% in 2024, its largest moves.
• Tracing IART's Inventory Average over 5 years: stood at $317.8 million in 2022, then gained by 18.91% to $377.9 million in 2023, then advanced by 14.57% to $433.0 million in 2024, then increased by 13.37% to $490.9 million in 2025, then gained by 0.6% to $493.9 million in 2026.
• Business Quant data shows IART's Inventory Average at $493.9 million in Q1 2026, $490.9 million in Q4 2025, and $477.1 million in Q3 2025.